Anastrozole and goserelin combination as first treatment for premenopausal receptor positive advanced or metastatic breast cancer: A phase II trial

被引：0
|
作者：
Roche, H. H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Thierry, D. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Chieze, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Pierre, K. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Veyret, C. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Abadie, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Campone, M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Florence, D. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构：
[1] Inst Claudius Regaud, Toulouse, France
[2] Ctr Francois Baclesse, F-14021 Caen, France
[3] CHU Poitiers, Poitiers, France
[4] CRLLC Eugene Marquis, Rennes, France
[5] Ctr Henri Becquerel, F-76038 Rouen, France
[6] Ctr Paul Papin, Angers, France
[7] Ctr Rene Gauducheau, St Herblain, France
[8] Claudius Regaud Hosp, Toulouse, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1079
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial
    Masuda, Norikazu
    Sagara, Yasuaki
    Kinoshita, Takayuki
    Iwata, Hiroji
    Nakamura, Seigo
    Yanagita, Yasuhiro
    Nishimura, Reiki
    Iwase, Hirotaka
    Kamigaki, Shunji
    Takei, Hiroyuki
    Noguchi, Shinzaburo
    [J]. LANCET ONCOLOGY, 2012, 13 (04): : 345 - 352
  • [32] A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer
    Massarweh, Suleiman
    Tham, Yee L.
    Huang, Jian
    Sexton, Krystal
    Weiss, Heidi
    Tsimelzon, Anna
    Beyer, Amanda
    Rimawi, Mothaffar
    Cai, Wei Yen
    Hilsenbeck, Susan
    Fuqua, Suzanne
    Elledge, Richard
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (03) : 819 - 827
  • [33] Randomized phase II trial of gefitinib plus anastrozole or fulvestrant in postmenopausal, metastatic breast cancer
    Carlson, R. W.
    O'Neill, A.
    Vidaurre, T.
    Gomez, H. L.
    Badve, S.
    Sledge, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer
    Isaacs, Claudine
    Herbolsheimer, Pia
    Liu, Minetta C.
    Wilkinson, Mary
    Ottaviano, Yvonne
    Chung, Gina G.
    Warren, Robert
    Eng-Wong, Jennifer
    Cohen, Philip
    Smith, Karen L.
    Creswell, Karen
    Novielli, Antonella
    Slack, Rebecca
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) : 137 - 143
  • [35] Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer
    Claudine Isaacs
    Pia Herbolsheimer
    Minetta C. Liu
    Mary Wilkinson
    Yvonne Ottaviano
    Gina G. Chung
    Robert Warren
    Jennifer Eng-Wong
    Philip Cohen
    Karen L. Smith
    Karen Creswell
    Antonella Novielli
    Rebecca Slack
    [J]. Breast Cancer Research and Treatment, 2011, 125 : 137 - 143
  • [36] A phase II study of pembrolizumab in combination with palliative radiotherapy for metastatic hormone receptor positive breast cancer
    Barroso-Sousa, Romualdo
    Gao, Hao
    Barry, William T.
    Krop, Ian E.
    Schoenfeld, Jonathan D.
    Tolaney, Sara M.
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [37] Treatment of metastatic breast cancer with intensified combination of docetaxel and mitoxantrone: A multicenter phase II trial
    Alexopoulos, A
    Malamos, N
    Giannakakis, T
    Mauroudis, D
    Panagos, G
    Agelaki, S
    Kosmas, C
    Souglakos, J
    Vardakis, N
    Apostolaki, F
    Georgoulias, V
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 27 - 27
  • [38] A phase II parallel group study with letrozole plus goserelin in premenopausal, and letrozole in postmenopausal metastatic breast cancer patients as first line hormone therapy
    Ro, J.
    Lee, K. S.
    Han, H.
    Lee, E.
    Kang, H. S.
    Kim, S. W.
    Kwon, Y.
    Nam, B.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 176 - 176
  • [39] Phase II study of Taxotere in advanced or/and metastatic breast cancer as a first or second line of treatment
    Borisova, TA
    Orel, NF
    Pirogova, NA
    Gorbounova, VA
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 28 - 28
  • [40] Goserelin plus letrozole as first- or second-line hormonal treatment in premenopausal patients with advanced breast cancer
    Yao, Shuyang
    Xu, Binghe
    Li, Qing
    Zhang, Pin
    Yuan, Peng
    Wang, Jiayu
    Ma, Fei
    Fan, Ying
    [J]. ENDOCRINE JOURNAL, 2011, 58 (06) : 509 - 516
12345